Skip to main content

View full-text article in PMC

. Author manuscript; available in PMC: 2015 Jun 4.

Published in final edited form as: Sex Transm Dis. 2010 Oct;37(10):637–643. doi: 10.1097/OLQ.0b013e3181e1a64a

TABLE 2.

HSV-2 and HIV Prevalence by Demographic and Drug Use Characteristics Among Never-Injector Drug Users, New York City, 2004–2009

	Total N (%)	HSV-2+ N (%)	HIV+ N (%)
Total	1418 (100)	859 (61)	233 (16)
Gender/MSM
Men (non-MSM)	956 (100)	482 (50)^*	112 (12)^*
MSM	114 (100)	82 (72)^*	52 (46)^*
Women	343 (100)	293 (85)^*	69 (20)^*
Race/ethnicity
Whites	74 (100)	29 (39)^*	4 (5)^†
Blacks	951 (100)	631 (66)^*	171 (18)^†
Hispanics	357 (100)	177 (50)^*	54 (15)^†
Other/mixed	36 (100)	22 (61)^*	4 (11)^†
Age
18–29	75 (100)	29 (39)^‡	7 (9)
30–39	372 (100)	198 (53)^‡	63 (17)
40–49	776 (100)	496 (64)^‡	132 (17)
50+	193 (100)	136 (70)^‡	31 (16)
Drug use
Heroin	518 (100)	280 (54)^*	51 (10)^*
Cocaine	586 (100)	317 (54)^*	69 (12)^*
Crack cocaine	1055 (100)	668 (63)^*	205 (19)^*

Significant difference by χ² test.

^*

P < 0.001.

^†

P < 0.05.

Significant difference by Cochran-Armitage test for trend.

^‡

P < 0.001.